Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Submitted by
admin
on April 22, 2017 - 1:14pm
Source:
Yahoo/Reuters
News Tags:
Europe
EMA
Sanofi
Regeneron
rheumatoid arthritis
Kevzara
Sarilumab
Headline:
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Do Not Allow Advertisers to Use My Personal information